S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7118 +0.12%
AFTER HRS · 19:05 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead

ALKS

Alkermes plc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
43.48
−0.63 −1.43%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $7.3BP/E 114.4DIV YIELD —FCF YIELD 3.04%REV TTM $1.7B +10.8%NET INCOME $66.1M −81.0%NET DEBT $1B52W 27.20 – 55.22NEXT EARNINGS Oct 28 EST.SEC XBRL · TTM TO Invalid Date

One year, everything drawn on

252 SESSIONS · DAILY CLOSES
57473625Oct 2 · EVP, CLO, Alkermes, Inc. sell $83KSep 3 · EVP, CLO, Alkermes, Inc. sell $98KSep 1 · EVP R&D, Chief Medical Officer sell $423KSep 29 · Gilbert Cisneros buyJul 30 · Gilbert Cisneros buyJul 28 · 10-Q filed (Q2 2026)Jul 28 · 10-Q filed (Q1 2026)Feb 25 · 10-K filed (FY 2025)Feb 25 · 10-K filed (Q4 2025)Oct 28 · 10-Q filed (Q3 2025)Jul 28 · 10-Q filed (Q2 2025)Jul 28 · 10-Q filed (Q1 2025)Feb 25 · 10-K filed (FY 2024)Feb 25 · 10-K filed (Q4 2024)Oct 28 · 10-Q filed (Q3 2024)Oct 28 · 10-Q filed (Q2 2024)Oct 28 · 10-Q filed (Q1 2024)Feb 25 · 10-K filed (FY 2023)Feb 25 · 10-K filed (Q4 2023)OCT 2025JAN 2026APRJUL
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-10-21
Insiders (90d): $604K net selling
Shorts (latest report): 14.7M short · −44K last period
Every line of the math
40WATCH

Congress is trading it

ALL 2
TradedMemberTypeAmount
Sep 29Gilbert Cisneros D·CABuy$1K–$15K
Jul 30Gilbert Cisneros D·CABuy$15K+

Insider activity

ALL 3
DateInsiderTypeValue
Oct 2EVP, CLO, Alkermes, Inc.Sell$83K
Sep 3EVP, CLO, Alkermes, Inc.Sell$98K
Sep 1EVP R&D, Chief Medical OfficerSell$423K
Watch ALKS. Know when insiders buy.
One email the day a filing lands. Free.